Stomach pain on Ozempic®

Abdominal pain as a common reaction

In Table 1 of the US label, abdominal pain is the fourth of five stomach and bowel reactions reported by at least 5% of people on Ozempic® and more often than on placebo. The Medication Guide calls it stomach (abdominal) pain and lists it among the most common side effects ^[1]. Europe classes it as common, and Canada builds a wider grouped term that also covers upper and lower abdominal pain, abdominal discomfort, tenderness and epigastric discomfort ^[2][3].

A smaller gap than the other stomach rows

Placebo matters a lot here. Close to one in twenty people on placebo reported abdominal pain, so the difference between the medicine and placebo is narrower than for diarrhea or vomiting. As with constipation, the 1 mg group reported slightly less than the 0.5 mg group in both the US and Canadian pools; neither document explains why ^[1][3].

Unlike nausea, vomiting and diarrhea, abdominal pain is not named in the label’s sentence about reactions clustering during dose escalation, so no timing should be assumed ^[1].

Three kinds of pain the label flags

• Severe, lasting pain in the stomach area, which may or may not come with vomiting and is sometimes felt through to the back: the Medication Guide links this to pancreatitis and says to stop Ozempic® and call your provider right away ^[1].
• Pain in the upper stomach with fever, yellowing of the skin or eyes, or clay-coloured stools: the guide lists these as possible gallbladder symptoms to report right away ^[1].
• Stomach problems that are severe or persistent in general: section 17 asks prescribers to tell patients to contact them, and section 5.7 reports severe stomach and bowel reactions in 0.4% on 0.5 mg and 0.8% on 1 mg, with none on placebo ^[1].

How often the serious causes appeared

Pancreatitis: across the glycemic control trials, an independent review confirmed acute pancreatitis in 7 people on Ozempic® and 3 on comparators, or 0.3 and 0.2 cases per 100 patient-years. Europe classes acute pancreatitis as uncommon, between 1 in 1,000 and 1 in 100 ^[1][2].

Gallstones: in the US placebo-controlled trials, cholelithiasis was reported in 1.5% on 0.5 mg and 0.4% on 1 mg, and in no one on placebo; inflamed gallbladder and gallbladder removal appear among later reports. Europe classes gallstones as common ^[1][2].

Bowel blockage: ileus and intestinal obstruction are listed among reports received after approval, with frequency that cannot be reliably estimated ^[1].

What research adds

A 2025 meta-analysis of 55 placebo-controlled trials with 106,395 participants found that GLP-1 medicines increased the risk of gallstones (about 2 more cases per 1,000 people) and probably reflux, but probably had little or no effect on pancreatitis, bowel obstruction, ulcers and most other serious stomach events ^[5].

A 2023 insurance-claims study of people without diabetes who started semaglutide or liraglutide for weight loss found higher risks of pancreatitis, bowel obstruction and gastroparesis than with bupropion-naltrexone, but not of biliary disease. The events were few, most came from liraglutide users, and the study could not confirm why each medicine was prescribed ^[4]. The two kinds of study answer different questions, which is one reason headlines about stomach risks can seem to disagree.

Why it may happen

What the label supports: abdominal pain is a recognised reaction above placebo, and semaglutide causes a minor delay in stomach emptying after meals ^[1].

What is plausible but unmeasured: food staying in the stomach longer, along with bloating and constipation, could make the belly feel sore. None of the official documents tests that link.

General background: MedlinePlus explains that pain spread over more than half of the belly is more typical of a stomach virus, indigestion or gas, whereas pain in one spot is more likely to come from an organ such as the appendix, gallbladder or stomach, and colicky pain that comes in waves is often caused by gallstones or kidney stones ^[6].

Other causes to keep in mind

• Less serious causes such as constipation, gas, irritable bowel syndrome, food intolerance, food poisoning and stomach flu ^[6].
• Heartburn, indigestion and reflux, which Ozempic® can also cause ^[1][6].
• Kidney stones, urinary infections, muscle strain and, in women, menstrual cramps, endometriosis, an ovarian cyst or an ectopic pregnancy ^[6].
• Conditions that need urgent care, including appendicitis, a blocked or twisted bowel, reduced blood supply to the gut and an abdominal aortic aneurysm ^[6].

What may help with mild pain

The Ozempic® documents do not suggest remedies for ordinary abdominal pain. MedlinePlus offers general steps for mild pain: sip water or other clear fluids, avoid solid food for the first few hours, and after vomiting return slowly to small amounts of mild foods. People with diabetes are reminded to check their blood sugar often ^[6].

It also suggests avoiding citrus, fatty or fried foods, tomato products, caffeine, alcohol and fizzy drinks while the pain settles, and not taking any medicine without talking to your provider ^[6]. These steps are for mild pain only; the patterns in the help table below need contact, not home care.

Describing the pain well

Clinicians find it easier to judge stomach pain when they know where it sits (upper, lower, one side or all over), whether it is cramping, burning, colicky or constant, how long each episode lasts, whether it spreads to the back or shoulder, and whether it follows meals or a recent injection. Noting fever, vomiting, a change in skin or stool colour, or being unable to pass stool is especially useful given the warnings above.

Ozempic® is a registered trademark of Novo Nordisk A/S. PepLabo is not affiliated with or endorsed by Novo Nordisk.